Duration of glutamate release after acute ischemic stroke

Stroke

Volumn 28, Issue 4, 1997, Pages 708-710

  Dávalos, Antoni ^a   Castillo, José ^b   Serena, Joaquín ^a   Noya, Manuel ^b  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b HOSPITAL GENERAL DE GALICIA   (Spain)

Author keywords

excitotoxicity; glutamate; neuroprotection; stroke outcome

Indexed keywords

EXCITOTOXIN; GLUTAMIC ACID;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; PRIORITY JOURNAL; STROKE;

EID: 0342981455     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.4.708     Document Type: Article

References (18)

1. Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol. 1986;19:105-111.
2. Hossmann K-A. Mechanisms of ischemic injury: is glutamate involved? In: Krieglstein J. Oberpichler-Schwenk H, eds. Pharmacology of Cerebral Ischemia 1994. Stuttgart, Germany: Medpharm Scientific Publishers; 1994:239-251.
3. Muir KW, Lees KR. Clinical experience with excitatory amino acid antagonist drugs. Stroke. 1995;26:503-513.
4. Takagi K, Ginsberg MD, Globus MYT, Dietrich D, Martinez E, Kraydieh S, Busto R. Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: correlation with histopathology. J Cereb Blood Flow Metab. 1993;13:575-585.
5. Matsumoto K, Graf R, Rosner G, Taguchi J, Heiss WD. Elevation of neuroactive substances in the cortex of cats during prolonged focal ischemia. J Cereb Blood Flow Metab. 1993;13:586-594.
6. Castillo J, Dávalos A, Naveiro J, Noya M. Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke. 1996;27:1060-1065.
7. Castillo J, Dávalos A, Noya M. Progression of ischaemic stroke and excitatory amino acids. Lancet. 1997;349:79-83.
8. Dávalos A, Cendra E, Teruel J, Martinez M, Genís D. Deteriorating ischemic stroke: risk factors and prognosis. Neurology. 1990; 40:1865-1869.
9. Baker CJ, Fiore AJ, Frazzini VI, Choudhri TF, Zubay GP, Solomon RA. Intraischemic hypothermia decreases the release of glutamate in the cores of permanent focal cerebral infarcts. Neurosurgery. 1995;36:994-1002.
10. Baker AJ, Moulton RJ, MacMillan VH, Shedden PM. Excitatory amino acids in cerebrospinal fluid following traumatic brain injury in humans. J Neurosurg. 1993;79:369-372.
11. Myseros JS, Bullock R. The rationale for glutamate antagonists in the treatment of traumatic brain injury. N Y Acad Sci. 1995;765: 262-272.
12. Bullock R, Zauner A, Woodward J, Young HF. Massive persistent release of excitatory amino acids following human occlusive stroke. Stroke. 1995;26:2187-2189.
13. Toni D, Fiorelli M, Gentile M, Bastianello S, Sacchetti ML, Argentino C, Pozzilli C, Fieschi C. Progressing neurological deficit secondary to acute ischemic stroke. Arch Neurol. 1995;52:670-675.
14. Dávalos A, Castillo J, Pumar JM, Noya M. Body temperature and fibrinogen are related to early neurological deterioration in acute ischemic stroke. Cerebrovasc Dis. In press.
15. Dávalos A, Toni D, Bastianello S, Castillo J for the ECASS Group. Predictors of early neurological deterioration in acute ischemic stroke. Stroke. 1997;28:251. Abstract.
16. Choi DW, Gedde M, Kriegstein AR. Glutamate neurotoxicity in cortical cell culture. J Neurosci. 1987;7:357-368.
17. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994;330: 613-621.
18. Shimada N, Graf R, Rosner G, Heiss WD. Ischemia-induced accumulation of extracellular amino acids in cerebral cortex, white matter, and cerebrospinal fluid. J Neurochem. 1993;330:613-621.